Six new research projects concerning Covid-19
On April 10, 2020, ANR announced the funding of 86 projects concerning Covid-19. Six are associated with ENS de Lyon laboratories. The SARS-CoV-2 infection is a global emergency for human health. The interferon response is the body's first barrier to defending viral infections. This host response is initiated by the recognition of viral elements by receptor and leads to the production of molecules, including interferon, that alert surrounding cells. This response then directly inhibits viral spread or enables the gathering of immune cells at the site of infection. For example, interferon is one of the current therapeutic treatments for patients with Covid-19.

